the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Pearly-Thinaah storm to second successive Hong Kong Open final

KUALA LUMPUR: National top women’s doubles pair Pearly Tan-M. Thinaah powered their way to back-to-back Hong Kong Open finals when they stunned top seed Baek Ha Na-Lee So Hee in the semi-finals of the 2024 edition in Kowloon, today.

The third seed duo survived a gruelling 74-minute rubber set battle against Ha Na-So Hee before prevailing 22-20, 17-21, 21-15, in the Super 500 tournament held in Hong Kong Coliseum.

This victory marks their third win over the world number two duo in four encounters.

Both pairs first met in the semi-finals of the French Open 2022, which went to the Malaysians way, 21-13, 21-17.

Pearly and Thinaah, the current world number eight, will now face either second-seeded Liu Sheng Shu and Tan Ning from China or fourth-seeded Kim So Yeong and Kong Hee Yong from South Korea, who meet in the other semifinal later.

Today’s result offers Pearly and Thinaah a chance to bounce back after their loss in last year’s final against Indonesia’s Apriyani Rahayu and Siti Fadia Silva Ramadhanti, who edged them out 21-14, 22-24, 9-21.

The Paris 2024 Olympic Games semi-finalists last claimed a title at the 2022 French Open, where they defeated Japan’s Mayu Matsumoto and Wakana Nagahara 21-19, 18-21, 21-15.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings